These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 1542794)
1. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794 [TBL] [Abstract][Full Text] [Related]
2. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310 [TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190. Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034 [TBL] [Abstract][Full Text] [Related]
4. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response. Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548 [TBL] [Abstract][Full Text] [Related]
5. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424 [TBL] [Abstract][Full Text] [Related]
6. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807 [TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of a specific receptor for mouse oncostatin M. Lindberg RA; Juan TS; Welcher AA; Sun Y; Cupples R; Guthrie B; Fletcher FA Mol Cell Biol; 1998 Jun; 18(6):3357-67. PubMed ID: 9584176 [TBL] [Abstract][Full Text] [Related]
8. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570 [TBL] [Abstract][Full Text] [Related]
9. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Ichihara M; Hara T; Kim H; Murate T; Miyajima A Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells. Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716 [TBL] [Abstract][Full Text] [Related]
11. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit. Modrell B; Liu J; Miller H; Shoyab M Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660 [TBL] [Abstract][Full Text] [Related]
12. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280 [TBL] [Abstract][Full Text] [Related]
13. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. Gearing DP; Bruce AG New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831 [TBL] [Abstract][Full Text] [Related]
14. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060 [TBL] [Abstract][Full Text] [Related]
15. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism. Hui W; Bell M; Carroll G Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300 [TBL] [Abstract][Full Text] [Related]
16. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. Hammacher A; Richardson RT; Layton JE; Smith DK; Angus LJ; Hilton DJ; Nicola NA; Wijdenes J; Simpson RJ J Biol Chem; 1998 Aug; 273(35):22701-7. PubMed ID: 9712900 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918 [TBL] [Abstract][Full Text] [Related]
18. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. Palmqvist P; Persson E; Conaway HH; Lerner UH J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157 [TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269 [TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. Gearing DP; Thut CJ; VandeBos T; Gimpel SD; Delaney PB; King J; Price V; Cosman D; Beckmann MP EMBO J; 1991 Oct; 10(10):2839-48. PubMed ID: 1915266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]